Viking Therapeutics stock is being watched by wall street, with some outlets suggesting it could significantly increase in value. The company's stock is considered a potential target for acquisition and its treatment vk2735 is in late-stage trials. Some reports speculate that the stock could potentially double or more, with some specific price targets mentioned, although the actual outcome is uncertain.